|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details显示文摘 | Hisanori Umehara Kazuichi Okazaki Yasufumi Masaki Mitsuhiro Kawano Motohisa Yamamoto Takako Saeki Shoko Matsui Takayuki Sumida Tsuneyo Mimori Yoshiya Tanaka Kazuo Tsubota Tadashi Yoshino Shigeyuki Kawa Ritsuro Suzuki Tsutomu Takegami Naohisa Tomosugi Nozo | 2012 | Modern Rheumatology2012，，1： | 4 |
| 2 | NK/T-Cell Lymphomas: Pathobiology, Prognosis and Treatment Paradigm显示文摘 | Ritsuro Suzuki | 2012 | Current Oncology Reports2012，，5： | 1 |
| 3 | The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0显示文摘 | Ritsuro Suzuki Shigeki Ohtake Jin Takeuchi Masami Nagai Yoshihisa Kodera Motohiro Hamaguchi Shuichi Miyawaki Takahiro Karasuno Shigetaka Shimodaira Ryuzo Ohno Shigeo Nakamura Tomoki Naoe | 2010 | International Journal of Hematology2010，，2： | 1 |
| 4 | Intravascular large B- cell lymphoma(I VLBCL) :a clinicopathologic study of 96 cases with special reference to the immunophenotypic heter- ogeneity of CD5 显示文摘 | TakuheiM Motoko Y Ritsuro S | 2007 | Blood2007，109，2： | 1 |
| 5 | Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors显示文摘 | Makoto Hirokawa Takahiro Fukuda Kazuteru Ohashi Michihiro Hidaka Tatsuo Ichinohe Koji Iwato Heiwa Kanamori Makoto Murata Toru Sakura Masahiro Imamura Soichi Adachi Ritsuro Suzuki Yasuo Morishima Hisashi Sakamaki | 2013 | Biology of Blood and Marrow Transplantation2013，，7： | 1 |
| 6 | Extranodal NK/T-cell lymphoma:diagnosis and treatment cues显示文摘 | Ritsuro S Kengo T Koichi O | | 0，，02： | 1 |
| 7 | The clinical characteristics of CD7 + CD56 + acute myeloid leukemias other than M0显示文摘 | Ritsuro Suzuki Shigeki Ohtake Jin Takeuchi Masami Nagai Yoshihisa Kodera Motohiro Hamaguchi Shuichi Miyawaki Takahiro Karasuno Shigetaka Shimodaira Ryuzo Ohno Shigeo Nakamura Tomoki Naoe | 2010 | International Journal of Hematology2010，，2： | 1 |
| 8 | Characterization of the amorphous state in metamict silicates and niobates by EXAFS and XANES analyses显示文摘 | Izumi Nakai Junji Akimoto Masayuki Imafuku Ritsuro Miyawaki Yoshinori Sugitani Kichiro Koto | 1987 | Physics and Chemistry of Minerals1987，，2： | 1 |
| 9 | A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details显示文摘 | Hisanori Umehara Kazuichi Okazaki Yasufumi Masaki Mitsuhiro Kawano Motohisa Yamamoto Takako Saeki Shoko Matsui Takayuki Sumida Tsuneyo Mimori Yoshiya Tanaka Kazuo Tsubota Tadashi Yoshino Shigeyuki Kawa Ritsuro Suzuki Tsutomu Takegami Naohisa Tomosugi Nozo | 2012 | Modern Rheumatology2012，，1： | 1 |
| 10 | Detection of Cyclin D1 Overexpression by Real-Time Reverse-Transcriptase-Mediated Quantitative Polymerase Chain Reaction for the Diagnosis of Mantle Cell Lymphoma显示文摘 | RITSURO S KAZUO T MASAYOSHI T | 2001 | AmJ Pathol2001，159，： | 1 |
| 11 | Progress in the treatment of NK-cell lymphoma/leukemia显示文摘Natural killer(NK)/T cell lymphoma includes two major subtypes of disease,specifically extranodal NK/T cell lymphoma,nasal type(ENKL)and aggressive NK cell leukemia(ANKL).Both are strongly associated with Epstein Barr virus and are prevalent in East Asia and Latin America.Except for that of limited-stage ENKL,the prognosis of both diseases was poor in the previous decade.The advent of non-anthracycline-based chemoradiotherapy has contributed to an improvement in ENKL prognosis,but there is still room for further treatment progress.Recently,the high efficacy of PD-1 antibody was reported in relapsed or refractory ENKL patients.This was later supported by the finding that PD-L1/PD-L2 genetic alterations are frequently observed in ENKL and ANKL patients.Due to the rarity of the disease,a standard treatment for ANKL remains to be established.Currently,allogeneic stem cell transplantation is the only curative treatment,and this is even applicable to chemo-resistant ANKL patients.In this review,we focus on recent treatment approaches for NK/T cell lymphomas including novel agents. | Ayumi Fujimoto Ritsuro Suzuki | 2021 | Journal of Cancer Metastasis and Treatment2021，7，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员